Molecular Blocking of CD23 Supports Its Role in the Pathogenesis of Arthritis
Jérôme Rambert, Maria Mamani-Matsuda, Daniel Moynet et al. · 2009
Read Molecular Blocking of CD23 Supports Its Role in the Pathogenesis of Arthritis by Jérôme Rambert, Maria Mamani-Matsuda, Daniel Moynet et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004834.txt.
Description
Jérôme Rambert and colleagues showed that molecular blocking of CD23 supports its role in arthritis pathogenesis, in PLOS ONE in 2009. CD23 is an activation antigen expressed by various hematopoietic and epithelial cells and detected in soluble forms in fluids. Initially known as the low affinity receptor for immunoglobulin E, CD23 displays various other physiological functions in immunity, allergy, and inflammatory joint disease studied.
Blocking CD23 altered disease relevant pathways in models. That supports causality, not mere association. CD23 becomes a candidate drug target. Arthritis affects millions with unmet needs. The work also raises clear questions that targeted studies can now address.
Catalog record
| CREATOR | Jérôme Rambert, Maria Mamani-Matsuda, Daniel Moynet et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004834